AKI-CRRT Debate Preliminary Round
Abstract List
|
A: The recommended CRRT dose of 20–25 mL/kg/hr should be used as a default. |
B: Regional citrate anticoagulation should be the default strategy for CRRT.
|
What will be covered |
This showcase features international debate teams discussing contemporary controversies in AKI, AKD, CRRT timing, extracorporeal blood purification, biomarkers, precision nephrology, sepsis-associated AKI, AI, and real-world data. |
|
What participants will learn |
• How to evaluate competing evidence and clinical uncertainty. • How to construct evidence-based arguments and counterarguments. • How to translate research into bedside decision-making and team-based discussion. |
|
Take-home value |
Participants will gain exposure to diverse regional perspectives, critical thinking frameworks, and evidence-based reasoning in controversial AKI-CRRT topics. |
|
Target audience |
Young nephrologists, intensivists, physician-scientists, fellows, trainees, and participants interested in academic medicine, clinical research, and international collaboration. |
|
Faculty/speakers |
International debate teams from Taiwan, Japan, South Korea, Singapore, Malaysia, the Philippines, Thailand, Vietnam, and Indonesia. |
|
Registration requirement / additional fee |
Included in congress registration unless otherwise specified. Team participation follows the debate program instructions. |
| Time | Session |
|---|---|
|
16:00
16:55
|
Kathleen Liu
Moderator
How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow Do I Care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices
|
|
16:55
17:50
|